Radioactive iodine ‘commonly overused’ in low-risk thyroid cancer
Survey of US patients suggests almost half are receiving the therapy despite guidelines advising it may not be needed
The use of radioactive iodine (RAI) to treat low-risk thyroid cancer appears to be common, despite contrary guideline advice, a US survey suggests.
Using data from the Surveillance Epidemiology and End Results (SEER) registries for Georgia and Los Angeles County, the researchers identified adults with low-risk thyroid cancer and linked them to their treating general surgeons, otolaryngologists and endocrinologists.
